Ticker

AQST

Aquestive Therapeutics, Inc.

7 catalysts on file

AQST

Aquestive Therapeutics, Inc.

CRL Confirmed

Anaphylm

Type I allergic reactions, including anaphylaxis

203d ago Jan 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AQST

Aquestive Therapeutics, Inc.

PDUFA Confirmed

Anaphylm

severe allergic reactions, including anaphylaxis

147d ago Mar 27, 2026

SEC 8-K verified 2mo ago

Countdown card →

AQST

Aquestive Therapeutics, Inc.

AdCom Confirmed

Anaphylm

Type I allergic reactions, including anaphylaxis

144d ago Mar 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AQST

Aquestive Therapeutics, Inc.

Catalyst AI-extracted

Anaphylm

treatment of Type I allergic reactions, including anaphylaxis

112d ago May 1, 2026

SEC 8-K verified 2mo ago

Countdown card →

AQST

Aquestive Therapeutics, Inc.

Phase 1 AI-extracted

AQST-108

androgenic alopecia

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AQST

Aquestive Therapeutics, Inc.

Phase 2 AI-extracted

Anaphylm

Type 1 allergic reactions, including anaphylaxis

52d ago ~ Jun 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

AQST

Aquestive Therapeutics, Inc.

Phase 3 AI-extracted

Anaphylm

Type I allergic reactions, including anaphylaxis

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →